Nancy J Kelley + Associates

A Special Conference for Real Estate, Design & Life Science Professionals

Nancy J Kelley serves on the Steering Committee for the meeting and was a keynote speaker.

Creating Specialized Life Science and Lab Space in New York City
The life science industry in New York is poised for rapid growth, but is constrained by the lack of available, affordable laboratory space in locations that allow a “clustering” effect, creating synergies where research, investment and technology transfer can take place to spawn new companies. The shortage of supply is further complicated by the lack of knowledge and understanding among the New York real estate community about the potential for the market, the specialized infrastructure required by life science companies, and the financial components of development and lease transactions of life science companies.

The Potential for Life Sciences Real Estate Expansion in NYC
Over 250 scientists, biotech, real estate, and design professionals joined together at the Life Sciences Real Estate Development Symposium to reimagine the way New York City capitalizes on future growth and new technological developments in biology, and to begin planning new environments to accommodate the projected rapid expansion of applied life sciences in the City and globally.

The newly formed NYC Builds Bio+ initiative, an interdisciplinary collaborative organization of leaders in real estate and life sciences, was announced at the meeting in anticipation of the projected unprecedented decade of growth ahead.

The Symposium focused on the potential for the expanding market, the specialized infrastructure required by life science companies, and the financial components of development and lease transactions of life science companies.

The meeting was especially timely with the City of New York recently announcing its intention to establish an Applied Life Sciences Hub, the flagship project of LifeSci NYC, a 10-year, $500 million commitment to the City’s life science sector.

“Future growth will come from expanding traditional institutions and corporations, and from new start-ups and technological developments such as synthetic biology. These industry innovators hold the promise for the development of applications across a broad range of industries such as energy, agriculture, healthcare, chemicals, materials and bioremediation.”

—Nancy J Kelley, president and CEO of Nancy J Kelley + Associates, and meeting co-organizer and steering committee member

The Symposium, led by the Symposium Steering Committee, was the first in a series of meetings intended to serve as the catalyst for more targeted initiatives that the New York City life science real estate community could collaboratively pursue during the projected and unprecedented decade of growth ahead. All proceeds from the symposium will be dedicated to supporting the launch of the newly created NYC Builds Bio+ Initiative to be founded in 2018.

AGENDA

8:00 AM – 8:30 AM – Registration and Continental Breakfast

8:30 AM – 8:45 AM – WELCOME

• Overview of the Meeting, Mitchel W. Simpler, PE, Managing Partner, Jaros, Baum & Bolles

8:45 AM – 9:00 AM – The 21st Century Will Be the Century of Biology

• Overview of the Changing Life Sciences Industry, Nancy J Kelley, JD/MPP, President and CEO, Nancy J Kelley + Associates

9:00 AM – 9:40 AM – Implications of the Century of Biology for NYC

• Moderator: John Powers, Executive Vice President, Boston Properties
• How does New York City Stack Up? Where does NYC Stand in the Life Sciences Industry? Steve Purpura, Vice Chairman, Managing Director of Life Sciences Consulting Group, CBRE
• What are the Site Selection Criteria for Life Sciences Real Estate and What are the Priority Geographies in New York? Bill Harvey, Managing Director, Newmark Knight Frank
• What are the Building Characteristics Required for Life Sciences? Steven Gifford, AIA, Principal, Perkins Eastman
• What is NYC EDC’s Vision for the Life Science Infrastructure Initiative and the Applied Life Sciences Hub? Doug Thiede, Senior Vice President, Healthcare and Life Science,  New York City Economic Development Corporation
• Life Sciences in the Hudson Square Portfolio, Matt Ashbaugh, Managing Director, Hines

9:40 AM – 10:20 AM – What Can New York City Learn from the Competition?

• Moderator: John Gilbert, Chief Operating Officer, Executive Vice President and Chief Technology Officer, Rudin Management Company
• David Manfredi, FAIA, CEO & Founding Principal, Elkus Manfredi Architects
• Rob Albro, Managing Director, King Street Properties
• Bill Kane,Senior Vice President, Biomed Realty

10:20 AM – 10:40 AM – BREAK
10:40 AM – 11:20 AM – The Traditional Opportunity: What Are the NYC Academic Institutions Doing in Life Sciences Development?

• Moderator: John Sabey, Chief Executive Officer, Sabey Corporation
• Joe Ienuso, Group Senior Vice President of Facilities and Real Estate at New York-Presbyterian
• Patrick J. Burke, FAIA, Assistant Vice President, Capital Project Management, Columbia University Medical Center
• Claudia M. Gorun, AIA, MBA

11:20 AM – 11:30 AM – The New Opportunity: Reimagining New York City Using Biology, Grimanesa Amorós, Artist
11:30 AM – 12:10 PM – Emerging Unique Opportunities for Life Sciences in New York City

• Moderator: Tommy Craig, Senior Managing Director, Hines
• The Emerging World of Grown Materials, Suzanne Lee, Founder, Biofabricate
• Learn, Create, Grow, Genspace and the Biodesign Challenge, Daniel Grushkin, Executive Director and Co-Founder, Genspace
• GP-write and the Center of Excellence for Engineering Biology, David Whelan, Nancy J Kelley + Associates
• JLABS, Kate Merton, Head of JLABS @ NYC

12:10 PM – 12:40 PM – LUNCH

 
12:40 PM – 1:30 PM – Commercial Opportunities for Life Sciences in New York City

• Moderator: James McKenna, President and Chief Executive Officer, Hunter Roberts Construction Group
• Modern Meadow, Andras Forgacs, Co-Founder and CEO
• Epibone, Blake Adair, Chief of Staff
• Opentrons Labworks, Will Canine, Co-Founder and Chief Product Officer

1:30 PM – 2:15 PM – Case Study for Adaptive Reuse: The New York Genome Center, New York Stem Cell Foundation, and 375 Pearl Street

• Moderator: Jonathan Mechanic, Partner and Chairman of the Real Estate Department, Fried Frank
• Kent Knight, AIA, Vice President, Elkus Manfredi Architects
• Brian Aronne, Senior Vice President, Project Executive, Hunter Roberts Construction Group
• Chris Horch, PE, Associate Partner, Jaros, Baum & Bolles
• Clete Casper, Director of Real Estate, Sabey Corporation 
• Lois Mate, AIA, Associate Partner, Ennead Architects

2:15 PM – 2:30 PM – Call to Action and Next Steps: Introducing NYC BIO Initiative

• Symposium Steering Committee

2:30 PM – 4:00 PM – RECEPTION

• ROBERT ALBRO, Managing Director, King Street Properties
• GRIMANESA AMOROS, Artist
• BRIAN ARONNE, Senior Vice President, Operations Manager and Project Executive, Hunter Roberts Construction Group
• MATT ASHBAUGH, Managing Director, Hines
• PATRICK J. BURKE, FAIA, Assistant Vice President, Columbia University Medical Center
• WILL CANINE, Co-Founder and CPO, OpenTrons Labworks
• TOMMY CRAIG, Senior Managing Director, Hines
• ANDRAS FORGACS, Co-Founder and CEO, Modern Meadow
• JOHN J. GILBERT III, Chief Operating Officer, Executive Vice President and Chief Technology Officer, Rudin Management Company
• CLAUDIA GORUN, AIA, MBA
• DANIEL GRUSHKIN, Executive Director, Genspace
• BILL HARVEY, Managing Director, Newmark Knight Frank
• CHRISTOPHER HORCH, PE, LEEP AP, CEA, Associate Partner, Jaros, Baum & Bolles
• JOE IENUSO, Senior Vice President of Facilities and Real Estate, New York-Presbyterian
• WILLIAM KANE, Senior Vice President, East Coast Leasing, Biomed Realty
• NANCY J. KELLEY, President and CEO, Nancy J Kelley + Associates

• KENT KNIGHT, AIA, LEED AP, Vice President, Elkus Manfredi Architects
• SUZANNE LEE, Founder, Biofabricate
• DAVID MANFREDI, FAIA, LEED AP, CEO and Founding Principal, Elkus Manfredi Architects
• LOIS E. MATE, AIA, Associate Partner, Ennead Architects
• JAMES C. MCKENNA, President and CEO, Hunter Roberts Construction Group
• JONATHAN L. MECHANIC, Partner and Chairman of the Real Estate Department, Fried Frank
• KATE MERTON, Head of JLabs @ NYC & Boston, Johnson & Johnson Innovation
• JOHN POWERS, Executive Vice President, NY Region, Boston Properties
• STEVE PURPURA, Vice Chairman, Managing Director of Life Science Consulting Group, CBRE
• MITCHEL W. SIMPLER, PE, FACEC, Managing Partner, Jaros, Baum & Bolles
• NINA TANDON, Co-Founder and CEO, Epibone
• DOUG THIEDE, Senior Vice President of Life Sciences & Healthcare, New York City Economic Development Corporation
• DAVID J. WHELAN, Consultant, Nancy J Kelley + Associates